Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Digital Realty Trust, Inc. (DLR) vs 10X Genomics Inc (TXG) Price & Performance

Digital Realty Trust, Inc.Trade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Digital Realty Trust, Inc. vs 10X Genomics Inc — how do they compare? Digital Realty Trust, Inc. trades at $174.82 (market cap $64.05B), while 10X Genomics Inc trades at $45.9 (market cap $5.81B). The key difference: Digital Realty Trust, Inc. is far larger — about 11× 10X Genomics Inc's market cap, and Digital Realty Trust, Inc. pays a 2.82% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.

DLRTXG
Market Cap
$64.05B$5.81B
Sector
Real EstateHealth
52-Week High
$203.91$45.80
52-Week Low
$147.93$11.34
Enterprise Value
$81.57B$5.36B
Dividend Yield
2.82%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Digital Realty Trust, Inc.

Digital Realty Trust (DLR) trades at $177.92, down 1.38% on the day, with a bearish technical signal and mixed earnings history. The company shows strong fundamentals with 2025 revenue of $6.11B and net income of $1.31B, though its P/E ratio of 47.19 suggests premium valuation. Recent news highlights DLR's $7.8B acquisition of Blackstone's data center stake, positioning it for AI-driven growth.

DLR presents a growth opportunity in data center infrastructure supported by AI demand, with a consensus price target of $219.50 implying 23% upside. Risks include high debt levels, execution of recent acquisitions, and interest rate sensitivity. Analyst sentiment remains bullish with 59.57% buy ratings, but investors should weigh valuation concerns against long-term expansion potential.

10X Genomics Inc

TXG trades at $41.77, down 2.25% today, with a bullish technical setup supported by moving averages. The company shows improving fundamentals with revenue growth to $642.82M in 2025 and narrowing losses, while recent collaborations with Cleveland Clinic and the Proteintech acquisition expand its diagnostic capabilities. Analyst sentiment is mixed with 45% buy ratings but a consensus price target below current levels.

The outlook suggests cautious optimism as TXG demonstrates operational improvement with positive cash flow generation, though profitability remains elusive. Key risks include execution challenges in new ventures and competitive pressures, while upside potential hinges on continued margin expansion and successful integration of recent acquisitions.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Digital Realty Trust, Inc.

Digital Realty owns and operates nearly 300 data centers worldwide. It has more than 35 million rentable square feet across five continents. Digital's offerings range from retail co-location, where an enterprise may rent a single cabinet and rely on Digital to provide all the accommodations, to cold shells, where hyperscale cloud service providers can simply rent much, or all, of a barren, power-connected building. In recent years, Digital Realty has de-emphasized cold shells and now primarily provides higher-level service to tenants, which outsource their related IT needs to Digital. Digital Realty has also moved more into the co-location business, increasingly serving enterprises and facilitating network connections. Digital Realty operates as a real estate investment trust.

Read more on DLR

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG